Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline

Br J Haematol. 2018 Aug;182(3):344-359. doi: 10.1111/bjh.15460. Epub 2018 Jul 15.

¹ NIHR BRC Oxford Molecular Diagnostic Centre, Oxford University Hospitals NHS Trust and Department of Oncology, University of Oxford, John Radcliffe Hospital, Oxford, UK.
² Department of Haematology, Aneurin Bevan University Health Board, Abergavenny, UK.
³ Haematology, Christie Hospital, Manchester, UK.
⁴ Haematology, Royal Marsden Hospital NHS Trust, London, UK.
⁵ Cardiff & Vale University Health Board, Cardiff, UK.
⁶ Haematology, Addenbrooke's Hospital, Cambridge, UK.
⁷ Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
⁸ Haematology, Royal Marsden NHS Trust, Sutton, UK.
⁹ Department of Haematology, University Hospital Leicester, Leicester, UK.
¹⁰ Haematology, Bournemouth and Christchurch Hospitals, Bournemouth, UK.
¹¹ NIHR-ACL Haematology, University of Birmingham, Birmingham, UK.
¹² Kings College Hospital, London, UK.
¹³ Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
¹⁴ University of Cambridge, Cambridge, UK.
¹⁵ Haematology, Leeds Teaching Hospital NHS Trust, Leeds, UK.

No abstract available

Keywords: chronic lymphocytic leukaemia; management of side effects; pre-therapy assessment; supportive care; therapy.

Publication types